Ali Ghorbani
1*, Farzad Jasemi-Zergani
11 Department of Nephrology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
*Corresponding Author: *Corresponding Author: Ali Ghorbani, Department of Nephrology, Dialysis and Kidney Transplantation Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. , Email:
dralighorbani@yahoo.com
Abstract
Implication for health policy/practice/research/medical education:Primary arteriovenous fistula (AVF), failure remains a major problem for hemodialysis patients. Vascular access thrombosis prophylaxis needs to start early in the end-stage renal disease patient. Ticlopidine seems to be effective and safe for prevention of primary AVF failure in hemodialysis patients.